DSI
GBT

Daiwa SB Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Daiwa SB Investments’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,521
Closed -$1.31M – 263
2018
Q3 		$1.31M Buy
34,521
+1,891
+6% +$83.8K 0.26% 66
2018
Q2 		$1.48M Buy
32,630
+16,561
+103% +$754K 0.36% 61
2018
Q1 		$776K Buy
16,069
+7,393
+85% +$412K 0.23% 81
2017
Q4 		$341K Buy
8,676
+5,482
+172% +$205K 0.09% 112
2017
Q3 		$99K Sell
3,194
-164
-5% -$4.61K 0.03% 162
2017
Q2 		$92K Buy
3,358
+108
+3% +$3.21K 0.03% 162
2017
Q1 		$120K Buy
+3,250
New +$81.9K 0.03% 156

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Daiwa SB Investments's GBT Position: Q4 2018 in Review

Daiwa SB Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2018, closing a stake of 34,521 shares — an estimated $1.31M sold.

Daiwa SB Investments first reported a position in GBT in Q1 2017 and held it in 7 quarters. The position peaked at $1.48M in Q2 2018. 190 funds tracked by Wall St. Rank hold GBT as of Q4 2018.

  • Daiwa SB Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Daiwa SB Investments sold 34,521 Global Blood Therapeutics, Inc. shares in Q4 2018, an estimated $1.31M.
  • Daiwa SB Investments first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 7 quarters.
  • Daiwa SB Investments's Global Blood Therapeutics, Inc. position peaked at $1.48M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2018.

Based on Daiwa SB Investments's 13F filing for Q4 2018, filed 16 Jan 2019.